Skip to main content
All lobbying filings

W STRATEGIES, LLC

W STRATEGIES, LLC filed a Q2 report for CALIFORNIA LIFE SCIENCES on July 18, 2025, reporting $40,000 in lobbying income.

Lobbying for CALIFORNIA LIFE SCIENCES · A public policy research and advocacy organization for California's biomedical industry.

All filings by W STRATEGIES, LLC · Everything CALIFORNIA LIFE SCIENCES has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3
Medicare/Medicaid

Transitional coverage for innovative medical devices (Ensuring Patient Access to Critical Breakthrough Products Act). H.R.1 - One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act. Implementation of the Inflation Reduction Act. H.R.1492 - EPIC Act.

Health Issues

Legislation to reform PBMs.

Taxation/Internal Revenue Code

H.R.1990- American Innovation and R&D Competitiveness Act of 2023.

 Bills named in this filing 4
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 946
    ORPHAN Cures Act
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • H.R. 1990
    American Innovation and R&D Competitiveness Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem